Feedback plc Stock
Your prediction
Feedback plc Stock
The Feedback plc price is unchanged compared to yesterday.
Pros and Cons of Feedback plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Feedback plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Feedback plc | 0.000% | -2.857% | 33.333% | -55.556% | -32.000% | -93.200% | -83.000% |
| Allerthal-werke-Ag | 0.000% | -0.769% | 3.200% | 17.273% | 19.444% | 9.322% | -10.417% |
| Cfc Industriebeteiligungen | 0.960% | -20.000% | 9.244% | -36.196% | 33.333% | -62.044% | -37.349% |
| Gatekeeper Systems Inc | -0.330% | -1.893% | 8.995% | 16.625% | -20.932% | 282.377% | 115.473% |
News
aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial
aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type
